ArticleJCI insight2024

Phase 1 trial evaluating safety and pharmacokinetics of HIV-1 broadly neutralizing mAbs 10E8VLS and VRC07-523LS.

Seemal F Awan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.